Endotoxin-Induced Acute Tubular Necrosis in Cirrhotic Rats

REFERENCES

• Andersen JB, Sörensen FH, Skjoborg H. Acute renal failure in association with choledocolithiasis. Acta Chir Scand 1971; 137: 81.
   PubMedGoogle Scholar
• Cardis DT, Reinhold RB, Woodruff PW, Fine J. Endotoxemia in man. Lanset 1972; i: 1381–1386.
   Google Scholar
• Dawson JL: Jaundice and anoxic renal damage: Protective effect of mannitol. Br Med J 1964; 28: 810–811.
   Google Scholar
• Earley LE. Conclusive remarks and presentation of diagnostic criteria of the hepatorenal syndrome. In Bartole E and Chiandussi L (eds), Hepato-renal Syndrome. Padova: Piccin Medical Books, 1978: 493–499.
   Google Scholar
• Epstein M, Berk DP, Hollenberg NK, Adams DF, Chalmers TC, Abrams HL, Merrill JP. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 1970; 49: 175–185.
   PubMed Web of Science ®Google Scholar
• Gillenwater JY, Dooley ES, Frohlich ED. Effects of encotoxin on renal function and hemodynamics. Am J Physiol 1963; 205: 293–297.
   PubMedGoogle Scholar
• Gronvall JA, Brunson JG. The generalized Schwartzman phenomenon in rats. Arch Pathol 1956; 62: 324–334.
   Google Scholar
• Kelleher SP, Robinette JB, Miller F, Conger JD. Effect of hemorrhagic reduction in blood pressure on recovery from acute renal failure. Kidney Int 1978; 31: 725–730.
   Google Scholar
• Kew MC, Brunt PW, Varma RR, Hourigan KJ, Williams HS, Sherlock S. Renal and intrarenal blood-flow in cirrhosis of the liver. Lancet 1971; ii: 504–510.
   Google Scholar
• Liehr H, Grun M, Thiel H, Brunswig D, Rasenack U. Endotoxin-induced liver cirrhosis and intravascular coagulation in rats enhanced by portacaval collateral circulation. Gut 1975; 16: 429–436.
   PubMed Web of Science ®Google Scholar
• Marshall WJ, Melean AEM. The effect of oral phenobarbitone on hepatic microsomal cytochrome p-450 and demethylation activity in rats fed normal and low protein diets. Biochem Pharmacol 1969; 18: 153–157.
   PubMed Web of Science ®Google Scholar
• McMenamin R, Davies L, Crosswell P. Druginduced interstitial nephritis, hepatitis and exfoliative dermatitis. Aust NZ J Med 1976; 6: 583.
   PubMedGoogle Scholar
• Papper S, Belsky JL, Bleifer KH. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features. Ann Intern Med 1959; 51: 759–773.
   PubMed Web of Science ®Google Scholar
• Shear L, Kleinerman J, Gabuzda GJ. Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am J Med 1965;184–198.
   Google Scholar
• Shirai M, Nishioka M, Shiga J, Mori M, Fukuda I, Kanegasaki S. Fate of 3H-labeled endotoxin in partially hepatectomized rats. Hepatogastroenterol 1988; 35: 107–110.
   PubMedGoogle Scholar
• Shirai M, Shiga J, Yoshimura A, Fukuda I, Kanegasaki S, Mori W. The organ distribution of [3H] endotoxin following partial hepatectomy. Jpn J Exp Med 1988; 58: 219–224.
   PubMedGoogle Scholar
• Solez K. Acute renal failure (“Acute tubular necrosis”. Infarction, and Cortical Necrosis). In Heptinstall RH, ed. Pathology of the kidney. 3rd ed. Boston: Little Brown, 1983: 1069–1148.
   Google Scholar
• Solez K, More-Maroger L, Sraer JD. The morphology of acute tubular necrosis in man: Analysis of 57 renal biopsies and a comparison with glycerol mode. Medicine 1979; 58: 362–376.
   PubMed Web of Science ®Google Scholar
• Terao K, So K, Moroi T, Ikeuchi T, Suyama T, Endo O, Fukushima K. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance. Gastroenterol 1977; 73: 539–542.
   PubMed Web of Science ®Google Scholar
• Triger DR, Alp MH, Wright R. Bacterial and dietary antibodies in liver diseases. Lancet 1972; i: 60–63.
   Google Scholar
• Triger DR, Boyer TD, Levin J. Portal and systemic bacteremia and endotoxemia in liver disease. Gut 1978; 19: 935–939.
   PubMed Web of Science ®Google Scholar
• Williams RD, Elliot DW, Zollinger RM. The effect of hypotension in obstructive jaundice. Arch Surg 1960; 81: 182.
   Google Scholar
• Wilkinson SP, Hirst D, Day DW, Williams R. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol 1978; 31: 101–107.
   PubMed Web of Science ®Google Scholar
• Zipser RD, Radvan GH, Kronborg IJ, Duke R, Little TE. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors. Gastroenterol 1983; 84: 697–703.
   PubMed Web of Science ®Google Scholar